Shinya Suzuki (鈴木真也), Ph.D. in Medical Science (University of Toyama), BCOP-JSPHCS, is the chief and clinical pharmacist at the National Cancer Hospital East in Japan. After completing his residency, he became a board-certified oncology pharmacist with the Japanese Society of Hospital Pharmacists (JSHP) and the Japanese Society of Pharmaceutical Health Care and Sciences (JSPHCS). Shinya is a member of the Institutional Review Board at the National Cancer Center Hospital East, representing the Pharmacy Department, and is also a key member of the department’s research unit.
His research interests lie in the evidence of clinical pharmacy services. While working as a clinical pharmacist at one of Japan’s leading cancer centers, he published over 15 original peer-reviewed articles in Japanese (seven as first author and 11 as corresponding author), as well as around 40 academic papers in English (11 as first author, 23 as corresponding author and three as a research collaborator) in international journals. Dr. Suzuki often serves as a corresponding author on papers in which he is involved because he has consistently and actively engaged in educating young pharmacists, particularly pharmacy residents, at the National Cancer Center Hospital East. With an H-index of 12, Dr. Suzuki has established a consistent and impactful publication record. Their work is widely recognized within the scientific community, receiving 321 citations across 274 articles.
Shinya Suzuki (鈴木真也), Ph.D. in Medical Science (University of Toyama), BCOP-JSPHCS, is the chief and clinical pharmacist at the National Cancer Hospital East in Japan. After completing his residency, he became a board-certified oncology pharmacist with the Japanese Society of Hospital Pharmacists (JSHP) and the Japanese Society of Pharmaceutical Health Care and Sciences (JSPHCS). Shinya is a member of the Institutional Review Board at the National Cancer Center Hospital East, representing the Pharmacy Department, and is also a key member of the department’s research unit.
His research interests lie in the evidence of clinical pharmacy services. While working as a clinical pharmacist at one of Japan’s leading cancer centers, he published over 15 original peer-reviewed articles in Japanese (seven as first author and 11 as corresponding author), as well as around 40 academic papers in English (11 as first author, 23 as corresponding author and three as a research collaborator) in international journals. Dr. Suzuki often serves as a corresponding author on papers in which he is involved because he has consistently and actively engaged in educating young pharmacists, particularly pharmacy residents, at the National Cancer Center Hospital East. With an H-index of 12, Dr. Suzuki has established a consistent and impactful publication record. Their work is widely recognized within the scientific community, receiving 321 citations across 274 articles.